Can GPR4 Be a Potential Therapeutic Target for COVID-19?
dc.contributor.author | Yang, Li V. | |
dc.contributor.author | Oppelt, Karen A. | |
dc.contributor.author | Thomassen, Mary Jane | |
dc.contributor.author | Marie, Mona A. | |
dc.contributor.author | Nik Akhtar, Shayan | |
dc.contributor.author | McCallen, Justin D. | |
dc.date.accessioned | 2022-08-07T01:18:16Z | |
dc.date.available | 2022-08-07T01:18:16Z | |
dc.date.issued | 2021-01-21 | |
dc.identifier.doi | 10.3389/fmed.2020.626796 | |
dc.identifier.issn | 2296-858X | |
dc.identifier.uri | http://hdl.handle.net/10342/10983 | |
dc.language.iso | en_US | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | inflammation | en_US |
dc.subject | endothelial cell | en_US |
dc.title | Can GPR4 Be a Potential Therapeutic Target for COVID-19? | en_US |
dc.type | Article | en_US |
ecu.journal.name | Frontiers in Medicine | en_US |
ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- YangCanGPR4BeaPotentialTherapeuticTargetforCOVID19.pdf
- Size:
- 356.99 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article